Sheng F, Li M, Yu J, Yang S, Zou L, Yang G
Front Immunol. 2025; 16:1533335.
PMID: 39925809
PMC: 11802536.
DOI: 10.3389/fimmu.2025.1533335.
Tripathi S, Sharma Y, Kumar D
Metabol Open. 2025; 25:100347.
PMID: 39876904
PMC: 11772974.
DOI: 10.1016/j.metop.2025.100347.
Cui X, Song Y, Han J, Yuan Z
Biochem Biophys Rep. 2025; 41():101902.
PMID: 39802394
PMC: 11721226.
DOI: 10.1016/j.bbrep.2024.101902.
Kim M, Kang H, Baek J, Cho M, Chung E, Kim S
Exp Hematol Oncol. 2024; 13(1):122.
PMID: 39702544
PMC: 11660887.
DOI: 10.1186/s40164-024-00588-2.
Kim H, Shin C, Park C, Lee D, Lee S, Chung J
Open Biol. 2024; 14(11):230397.
PMID: 39533922
PMC: 11558241.
DOI: 10.1098/rsob.230397.
Bone mineral density affects tumor growth by shaping microenvironmental heterogeneity.
Whitman M, Mantri M, Spanos E, Estroff L, De Vlaminck I, Fischbach C
Biomaterials. 2024; 315:122916.
PMID: 39490060
PMC: 11658005.
DOI: 10.1016/j.biomaterials.2024.122916.
Ovarian cancer-derived IL-4 promotes immunotherapy resistance.
Mollaoglu G, Tepper A, Falcomata C, Potak H, Pia L, Amabile A
Cell. 2024; 187(26):7492-7510.e22.
PMID: 39481380
PMC: 11682930.
DOI: 10.1016/j.cell.2024.10.006.
Re-programming by a six-factor-secretome in the patient tumor ecosystem during nutrient stress and drug response.
Elghetany M, Pan J, Sekar K, Major A, Mf Su J, Adesina A
iScience. 2024; 27(10):110932.
PMID: 39474075
PMC: 11519416.
DOI: 10.1016/j.isci.2024.110932.
miR-1226-5p is involved in radioresistance of colorectal cancer by activating M2 macrophages through suppressing IRF1.
Choi J, Seok H, Lee D, Kwon J, Shin U, Shin I
J Transl Med. 2024; 22(1):980.
PMID: 39472937
PMC: 11523791.
DOI: 10.1186/s12967-024-05797-1.
Study on correlation between CXCL13 and prognosis and immune characteristics of ovarian cancer.
Wang Y, Cheng X, Li W, Zhang H
Medicine (Baltimore). 2024; 103(43):e40272.
PMID: 39470479
PMC: 11521060.
DOI: 10.1097/MD.0000000000040272.
Macrophages in the inflammatory response to endotoxic shock.
Zhao X, Wang M, Zhang Y, Zhang Y, Tang H, Yue H
Immun Inflamm Dis. 2024; 12(10):e70027.
PMID: 39387442
PMC: 11465138.
DOI: 10.1002/iid3.70027.
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy.
Li Q, Geng S, Luo H, Wang W, Mo Y, Luo Q
Signal Transduct Target Ther. 2024; 9(1):266.
PMID: 39370455
PMC: 11456611.
DOI: 10.1038/s41392-024-01953-7.
Integrating mechanism-based T cell phenotypes into a model of tumor-immune cell interactions.
Tangella N, Cess C, Ildefonso G, Finley S
APL Bioeng. 2024; 8(3):036111.
PMID: 39175956
PMC: 11341129.
DOI: 10.1063/5.0205996.
P53-associated lncRNAs regulate immune functions and RNA-modifiers in gastric cancer.
Huanjie Z, Bukhari I, Fazhan L, Wen H, Wang J, Wanqing W
Heliyon. 2024; 10(15):e35228.
PMID: 39166030
PMC: 11334848.
DOI: 10.1016/j.heliyon.2024.e35228.
Chitosan-based biomaterial delivery strategies for hepatocellular carcinoma.
Wang X, Yang Y, Zhao S, Wu D, Li L, Zhao Z
Front Pharmacol. 2024; 15:1446030.
PMID: 39161903
PMC: 11330802.
DOI: 10.3389/fphar.2024.1446030.
Bone mineral density affects tumor growth by shaping microenvironmental heterogeneity.
Whitman M, Mantri M, Spanos E, Estroff L, De Vlaminck I, Fischbach C
bioRxiv. 2024; .
PMID: 39091735
PMC: 11291034.
DOI: 10.1101/2024.07.19.604333.
Reduced Abundance of in Mucosa-associated Microbiota Is Associated with Distal Colorectal Cancer Metastases Possibly through an Altered Local Immune Environment.
Ota G, Inoue R, Saito A, Kono Y, Kitayama J, Sata N
J Anus Rectum Colon. 2024; 8(3):235-245.
PMID: 39086872
PMC: 11286368.
DOI: 10.23922/jarc.2024-014.
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside.
Yin Y, Feng W, Chen J, Chen X, Wang G, Wang S
Exp Hematol Oncol. 2024; 13(1):72.
PMID: 39085965
PMC: 11292955.
DOI: 10.1186/s40164-024-00539-x.
Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer.
Tsutsumi E, Macy A, LoBello J, Hastings K, Kim S
PLoS One. 2024; 19(7):e0304194.
PMID: 38968186
PMC: 11226078.
DOI: 10.1371/journal.pone.0304194.
Engineering nanoparticles-enabled tumor-associated macrophages repolarization and phagocytosis restoration for enhanced cancer immunotherapy.
Gong Y, Gao W, Zhang J, Dong X, Zhu D, Ma G
J Nanobiotechnology. 2024; 22(1):341.
PMID: 38890636
PMC: 11184870.
DOI: 10.1186/s12951-024-02622-1.